Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Owlet (OWLTW) Change in Cash (2020 - 2026)

Owlet (OWLTW) reported Change in Cash of -$2000.0 for Q1 2026, up 99.95% year-over-year from -$1000.2 in Q1 2025, and down 100.01% on a QoQ basis from $17.0 million in Q4 2025.

Owlet (OWLTW) has 7 years of Change in Cash data on file, last reported at -$2000.0 in Q1 2026.

  • Quarterly Change in Cash rose 99.95% year-over-year to -$2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.4 million (up 1465.36% YoY) and the FY2025 annual result came in at $20.4 million, up 400.25% from the prior year.
  • Change in Cash retreated to -$2000.0 in Q1 2026 per OWLTW's latest filing, from $17.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $17.0 million in Q4 2025 and bottomed at -$31.5 million in Q2 2022.
  • The 5-year median for Change in Cash is -$19000.0 (2023), against an average of -$3.2 million.
  • The widest annual swing landed in 2024, when Change in Cash plunged 15868.42%; it then surged 1455.0% in 2025.
  • Tracing OWLTW's Change in Cash over 5 years: stood at -$11.9 million in 2022, then surged by 111.66% to $1.4 million in 2023, then slumped by 189.87% to -$1.3 million in 2024, then surged by 1455.0% to $17.0 million in 2025, then tumbled by 100.01% to -$2000.0 in 2026.
  • Per Business Quant, the three latest OWLTW Change in Cash figures stand at -$2000.0 (Q1 2026), $17.0 million (Q4 2025), and $1.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.72 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -1.13 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -136.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -504.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -492.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.23 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.90 Mn
10 Owlet - - 12.24 Mn -2,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2,000.00
Dec 31, 2025 16.95 Mn
Sep 30, 2025 1.93 Mn
Jun 30, 2025 5.52 Mn
Mar 31, 2025 -4.02 Mn
Dec 31, 2024 -1.25 Mn
Sep 30, 2024 6.52 Mn
Jun 30, 2024 -3.03 Mn
Mar 31, 2024 1.84 Mn
Dec 31, 2023 1.39 Mn
Sep 30, 2023 -9.58 Mn
Jun 30, 2023 -19,000.00
Mar 31, 2023 13.53 Mn
Dec 31, 2022 -11.94 Mn
Sep 30, 2022 -14.08 Mn
Jun 30, 2022 -31.48 Mn
Mar 31, 2022 -26.32 Mn
Dec 31, 2021 -19.84 Mn
Sep 30, 2021 102.68 Mn
Jun 30, 2021 -593,000.00
Mar 31, 2021 -4.20 Mn
Dec 31, 2020 1.29 Mn
Sep 30, 2020 1.44 Mn
Jun 30, 2020 25,000.00